Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Lord

Showing results (51-60 of 222) with videos related to

Pageof 23
Sort By:
Current Opinion in Genetics & Development|January 25, 2011
Searching for synthetic lethality in cancerRachel Brough, Jessica R Frankum, Sara Costa-Cabral, et al.
Nature Genetics|November 30, 2023
Complex synthetic lethality in cancerColm J Ryan, Lovely Paul Solomon Devakumar, Stephen J Pettitt, et al.
EMBO Reports|July 5, 2017
Structural basis for recruitment of BRCA2 by PALB2Antony W Oliver, Sally Swift, Christopher J Lord, et al.
EMBO Reports|July 18, 2009
Structural basis for recruitment of BRCA2 by PALB2Antony W Oliver, Sally Swift, Christopher J Lord, et al.
The Journal of Pathology|May 21, 2011
Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expressionNeil Rajan, John Burn, James Langtry, et al.
Cancer Research|May 3, 2011
High-throughput RNAi screening reveals novel regulators of telomeraseMaria Antonietta Cerone, Darren J Burgess, Cristina Naceur-Lombardelli, et al.
DNA Repair|September 8, 2007
Functional analysis of Drosophila melanogaster BRCA2 in DNA repairRachel Brough, Debbie Wei, Sophie Leulier, et al.
EMBO Molecular Medicine|April 8, 2010
Aurora-A expressing tumour cells are deficient for homology-directed DNA double strand-break repair and sensitive to PARP inhibitionTony Sourisseau, Despina Maniotis, Afshan McCarthy, et al.
Molecular Cell|July 6, 2022
Captured snapshots of PARP1 in the active state reveal the mechanics of PARP1 allosteryÉlise Rouleau-Turcotte, Dragomir B Krastev, Stephen J Pettitt, et al.
Oncotarget|April 18, 2015
Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivityJessica Frankum, Pavel Moudry, Rachel Brough, et al.
Pageof 23

Showing results (51-60 of 222) with videos related to

Sort By:
Pageof 23
Current Opinion in Genetics & Development|January 25, 2011
Searching for synthetic lethality in cancerRachel Brough, Jessica R Frankum, Sara Costa-Cabral, et al.
Nature Genetics|November 30, 2023
Complex synthetic lethality in cancerColm J Ryan, Lovely Paul Solomon Devakumar, Stephen J Pettitt, et al.
EMBO Reports|July 5, 2017
Structural basis for recruitment of BRCA2 by PALB2Antony W Oliver, Sally Swift, Christopher J Lord, et al.
EMBO Reports|July 18, 2009
Structural basis for recruitment of BRCA2 by PALB2Antony W Oliver, Sally Swift, Christopher J Lord, et al.
The Journal of Pathology|May 21, 2011
Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expressionNeil Rajan, John Burn, James Langtry, et al.
Cancer Research|May 3, 2011
High-throughput RNAi screening reveals novel regulators of telomeraseMaria Antonietta Cerone, Darren J Burgess, Cristina Naceur-Lombardelli, et al.
DNA Repair|September 8, 2007
Functional analysis of Drosophila melanogaster BRCA2 in DNA repairRachel Brough, Debbie Wei, Sophie Leulier, et al.
EMBO Molecular Medicine|April 8, 2010
Aurora-A expressing tumour cells are deficient for homology-directed DNA double strand-break repair and sensitive to PARP inhibitionTony Sourisseau, Despina Maniotis, Afshan McCarthy, et al.
Molecular Cell|July 6, 2022
Captured snapshots of PARP1 in the active state reveal the mechanics of PARP1 allosteryÉlise Rouleau-Turcotte, Dragomir B Krastev, Stephen J Pettitt, et al.
Oncotarget|April 18, 2015
Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivityJessica Frankum, Pavel Moudry, Rachel Brough, et al.
Pageof 23